We have a proven track record of successful consulting work. Previous client work includes clinical stage through launch commercialization planning, early asset commercialization input and planning, strategic and tactical brand planning, multi-channel HCP and patient engagement strategies, global cross-functional KOL engagement plans, and ongoing interim marketing leadership.
Small, Pre-Revenue Rare Disease Company:
Building a Commercialization Strategy and Preparing for Launch
Situation: A small founder-led company with impressive scientific and technical expertise sought rare disease commercialization expertise to complement and augment a leadership team who had never launched a rare disease therapy.
Consulting Approach: We worked hand-in-hand with the CCO as an extension of the team to craft the inaugural strategic plan and integrated roadmap. We helped to define the overarching vision, goals, and objectives, and then developed the cross-functional global go-to-market omnichannel plan inclusive of multi-stakeholder messaging and tactical deployment. We gathered internal and external insights to shape the core messages that would resonate across stakeholders and geographies, and then worked cross-functionally with senior leadership to develop multi-channel tactical plans to reach key stakeholders.
Impact: We developed and managed this strategic planning process from start to finish, including establishing strategic imperatives to prepare for launch, creating a cohesive commercialization roadmap, and identifying clear milestones and success metrics, all while ensuring organizational alignment.
Situation: A well-established leader in the genomics market, the company sought to scale their organizational infrastructure, refresh and expand their product offering, and strengthen their commercial capabilities. In parallel, the company wanted to establish a center of marketing excellence based on key market insights driving sound strategies as they scaled the business.
Consulting Approach: We worked in close collaboration with a cross-functional team to establish and build the Marketing team’s annual and long-range strategic and tactical planning. We managed a wide range of marketing workstreams while concurrently developing comprehensive strategic marketing plans and tactical plans by business unit.
Impact: We built and delivered comprehensive strategic plans to enable the company to reach new biopharma customers. We also delivered the company’s first integrated customer engagement strategy and omnichannel tactical plans for a new precision oncology business.
Situation: Leading into a critical product launch for the company, the commercial leadership sought to understand and benchmark patient engagement strategies for rare diseases. The brand team sought to augment their experience through consulting expertise of tactical opportunities and best practices for patient engagement.
Consulting Approach: We initiated a multi-stage approach to first identify brand goals and objectives, then benchmark industry best practices, and finally lead and manage the process to identify, select, and onboard a brand agency of record for the patient marketing team.
Impact: We crystallized best practice patient engagement tactics to guide the brand team’s strategic planning and budget decisions and successfully onboarded an inaugural brand agency of record following a highly competitive selection process.
Situation: A leading cell therapy company reorganized their internal team structure to form cross-functional Program and Product Teams to optimize long range planning and commercial success. The Head of Global Market Access, reporting directly to the company’s President, sought market access strategic planning expertise to serve as the global lead for the solid tumor early pipeline Product Teams.
Consulting Approach: We collaborated as an extension of the Global Market Access team to serve as the Market Access strategy lead in all solid tumor early pipeline program strategy and product planning workstreams, including cross-functional team meetings and executive leadership discussions. We also provided thought partnership for the Global Market Access leadership team in their portfolio planning.
Impact: We provided critical input, recommendations, and insights for the solid tumor franchise leadership and executive leadership to guide key strategic decisions regarding the pipeline.